Vladimir Trukhan
Vladimir Trukhan
I.M. Sechenov First Moscow State Medical University
Verified email at
Cited by
Cited by
Trends in antidiabetic drug discovery: FDA approved drugs, new drugs in clinical trials and global sales
AD Dahlén, G Dashi, I Maslov, MM Attwood, J Jonsson, V Trukhan, ...
Frontiers in Pharmacology 12, 807548, 2022
Translational application of circulating DNA in oncology: review of the last decades achievements
NO Tuaeva, L Falzone, YB Porozov, AE Nosyrev, VM Trukhan, L Kovatsi, ...
Cells 8 (10), 1251, 2019
Draft genome sequences of Hirudo medicinalis and salivary transcriptome of three closely related medicinal leeches
VV Babenko, OV Podgorny, VA Manuvera, AS Kasianov, AI Manolov, ...
BMC genomics 21 (1), 1-16, 2020
Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens
EN Grafskaia, KD Nadezhdin, IA Talyzina, NF Polina, OV Podgorny, ...
European Journal of Medicinal Chemistry 180, 143-153, 2019
Design and synthesis of new models for diiron biosites
VM Trukhan, ON Gritsenko, E Nordlander, AA Shteinman
Journal of Inorganic Biochemistry 79 (1-4), 41-46, 2000
Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagonists to the NK3 receptor
HR Hoveyda, MO Roy, S Blanc, S Noël, JM Salvino, MA Ator, G Fraser
Bioorganic & medicinal chemistry letters 21 (7), 1991-1996, 2011
Tetranuclear iron (III) complexes of an octadentate pyridine-carboxylate ligand and their catalytic activity in alkane oxidation by hydrogen peroxide
EA Gutkina, VM Trukhan, CG Pierpont, S Mkoyan, VV Strelets, ...
Dalton Transactions, 492-501, 2006
Systematic synthesis of functional unsymmetric FeZn model complexes for plant purple acid phosphatases
M Jarenmark, H Carlsson, VM Trukhan, M Haukka, SE Canton, ...
Inorganic Chemistry Communications 13 (3), 334-337, 2010
First structural-functional model of methane monooxygenase
VM Trukhan, VV Polukhov, IV Sulimenkov, NS Ovanesyan, NA Koval'chuk, ...
Kinetics and catalysis 39 (6), 788-791, 1998
Synthesis and characterization of iron (III) complexes of a new ligand containing a potentially bridging carboxylate; structural characterization of a helical tetranuclear iron …
VM Trukhan, AA Shteinman, CG Pierpont, KB Jensen, E Nordlander
Chemical Communications, 1193-1194, 1999
A binuclear iron (III) complex of a new tridentate binucleating ligand, 2-(2, 2′-bipyrid-6-yl) methoxybenzoic acid
VM Trukhan, AA Shteinman
Russian chemical bulletin 46 (1), 202-203, 1997
Design, synthesis and biological evaluation of neogliptin, a novel 2-azabicyclo [2.2. 1] heptane-based inhibitor of dipeptidyl peptidase-4 (DPP-4)
IO Maslov, TV Zinevich, OG Kirichenko, MV Trukhan, SV Shorshnev, ...
Pharmaceuticals 15 (3), 273, 2022
Synthesis, structure, and properties of a new trinuclear iron cluster, [(MeOH)(H2O)2Fe3(μ3-O)(μ-OOCC6H4OCH2C5H4NH)6] (ClO4)7 · · 8MeOH · 3.5H2O
VM Trukhan, IL Eremenko, NS Ovanesyan, AA Pasynskii, IA Petrunenko, ...
Russian chemical bulletin 45, 1981-1987, 1996
A new method of synthesis of methyl N-Boc-2,3-dehydropyrrolidine- and piperidine-2-carboxylates
VS Kublitskii, AE Stepanov, VM Trukhan
Russian Journal of Organic Chemistry 44, 933-934, 2008
Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice
FA Lagunas-Rangel, D Koshelev, A Nedorubov, L Kosheleva, V Trukhan, ...
Frontiers in Endocrinology 13, 2702, 2022
New type of polydentate ligands for modeling of binuclear metallobiocenters
VM Trukhan, E Nordlander, AA Shteinman
Green enabling technologies for competitive synthesis of pharmaceutical lead compounds
S Tagliapietra, A Binello, F Bucciol, V Trukhan, M Colia, G Cravotto
Current Pharmaceutical Design 26 (44), 5700-5712, 2020
Synthesis and structure of binuclear iron(ii) complex with the cage-like ligand as a model of methane monooxygenase
EA Turitsyna, VM Trukhan, AA Shteinman
Russian Chemical Bulletin 60, 2088-2093, 2011
Current Trends in Steroid Chemistry
MN Sokolov, VV Rozhkov, VM Trukhan, NL Shimanovskii
Pharmaceutical Chemistry Journal, 1-11, 2023
Using Liposomal and Intranasal Drugs and Pioglitazone for the Treatment and Prevention of Alzheimer’s Disease
VV Veselov, NN Eroshchenko, VM Trukhan, AV Zvyagin, AE Nosyrev
Pharmaceutical Chemistry Journal, 1-9, 2023
The system can't perform the operation now. Try again later.
Articles 1–20